Severe nonproliferative diabetic retinopathy is an advanced stage of diabetic eye disease that can damage the retina and threaten sight. Many people with severe nonproliferative diabetic retinopathy have no clear symptoms at first, but some notice blurred vision, floaters, or trouble seeing at night. Not everyone will have the same experience. Severe nonproliferative diabetic retinopathy usually develops over years in people living with diabetes, and without treatment it can progress to vision loss or blindness, but it is not usually fatal on its own. Treatment focuses on controlling blood sugar, blood pressure, and cholesterol, and careful eye follow-up helps catch early symptoms of severe nonproliferative diabetic retinopathy before more intensive care such as laser treatment or eye injections is needed.
How many people live with Severe nonproliferative diabetic retinopathy?
About 103 million people worldwide were living with diabetic retinopathy, the broader diabetes-related eye disease that includes severe nonproliferative diabetic retinopathy, in 2020 (Teo et al., 2021); because this severe stage is not usually counted separately and likely makes up about 5% to 10% of diabetic retinopathy cases, the worldwide number is only an estimate, around 5 to 10 million, not a direct count. In the United States, about 9 to 10 million people were living with diabetic retinopathy in 2021 (National Eye Institute, 2024), which suggests roughly 500,000 to 1 million people may be living with severe nonproliferative diabetic retinopathy, again as an estimate rather than a direct count.
Overview
Severe nonproliferative diabetic retinopathySymptoms
Severe nonproliferative diabetic retinopathy may cause blurry or fluctuating vision, dark spots or floaters, and trouble seeing clearly at night. In early symptoms of severe nonproliferative diabetic retinopathy, many people notice little or nothing at first.
Outlook and prognosis
With severe nonproliferative diabetic retinopathy, vision can remain stable for a time, but the risk of progressing to sight-threatening disease is high without close follow-up. Good blood sugar, blood pressure, and cholesterol control, plus timely eye treatment, can help protect vision.
Causes and risk factors
Severe nonproliferative diabetic retinopathy is mainly driven by long-term high blood sugar damaging retinal blood vessels. Risk rises with longer diabetes duration, high blood pressure, high cholesterol, smoking, kidney disease, pregnancy, and poor glucose control.
Genetic influences
Genes can influence who is more likely to develop Severe nonproliferative diabetic retinopathy and how fast it worsens, but they are only part of the picture. Blood sugar, blood pressure, and diabetes duration usually matter more than inherited genetic variations.
Diagnosis
Severe nonproliferative diabetic retinopathy is diagnosed during a dilated eye exam, often with retinal photos or scans. Eye doctors look for bleeding, blocked blood vessels, and swelling, alongside your diabetes history and vision changes.
Treatment and drugs
Treatment for severe nonproliferative diabetic retinopathy focuses on protecting vision and slowing damage. This often means tight blood sugar, blood pressure, and cholesterol control, with regular eye visits. Some people also need laser treatment, eye injections, or surgery.
Symptoms
Severe nonproliferative diabetic retinopathy can affect vision in uneven, frustrating ways, and some people notice very little at first. At this stage, the tiny blood vessels in the retina are badly stressed and damaged, but symptoms do not always match how advanced the eye disease is. You might notice small changes at first, such as blur that comes and goes, more trouble reading, or difficulty seeing in dim light. Severe nonproliferative diabetic retinopathy may also be picked up on a diabetic eye exam before day-to-day vision changes become obvious.
Even severe nonproliferative diabetic retinopathy may cause no clear symptoms at first. Many people feel their vision is mostly normal until swelling, bleeding, or reduced blood flow starts to affect sight.
Vision can look hazy, soft, or out of focus, and the amount of blur may change from day to day. The early symptoms of severe nonproliferative diabetic retinopathy are often subtle, so reading text messages or seeing faces across a room may simply feel more tiring.
You may see dark specks, threads, or cobweb-like shapes drifting across your vision. These can happen when small amounts of blood or debris enter the clear gel inside the eye, and a sudden increase can be more concerning.
Some people notice blank, dim, or shadowy areas in their field of view. This can make it harder to notice steps, curbs, or objects off to the side.
How people usually first notice Severe nonproliferative diabetic retinopathy?
Severe nonproliferative diabetic retinopathy is often first noticed in a quieter way than people expect, because many living with it have no warning signs at first and only learn about it during a dilated eye exam for diabetes. When symptoms do show up, the first signs of severe nonproliferative diabetic retinopathy can include blurred or fluctuating vision, trouble reading, dark spots or floaters, and sometimes patchy areas of missing vision as damaged retinal blood vessels begin to leak or close off. Because these changes can build gradually and painlessly, regular diabetic eye screening is often what catches it before vision loss becomes more serious.
Types of Severe nonproliferative diabetic retinopathy
Severe nonproliferative diabetic retinopathy does not have formal subtypes in the way some diseases do. Instead, doctors usually describe variations of severe nonproliferative diabetic retinopathy by the pattern of damage seen in the retina during an eye exam. Symptoms don’t always look the same for everyone. Many people have few or no clear symptoms at first, while others notice blurred vision, patchy sight, or trouble seeing fine detail as the retinal changes become more advanced.
Widespread bleeding
This pattern means there are many tiny retinal bleeds and swollen small blood vessels across several areas of the retina. Vision may stay normal for a while, but some people notice blurry spots, dimmer vision, or more trouble reading. Among the types of severe nonproliferative diabetic retinopathy, this is one of the most common patterns doctors use to judge severity.
Venous beading
In this variation, some retinal veins look uneven or beaded because the blood vessels are under stress from diabetes. Symptoms are often subtle, but many living with severe nonproliferative diabetic retinopathy may notice fluctuating blur or reduced sharpness, especially when blood sugar levels are changing.
IRMA pattern
This pattern involves abnormal small blood vessel channels inside the retina, which can signal that parts of the eye are not getting enough oxygen. Some may have no symptoms, while others notice increasing blur, faded detail, or areas of vision that seem less clear. This finding matters because it can mean the eye is closer to progressing to proliferative diabetic retinopathy.
Can I slow down the onset of symptoms?
Partly: there is good evidence that people with severe nonproliferative diabetic retinopathy may be able to slow worsening and delay vision symptoms by keeping blood sugar, blood pressure, and cholesterol well controlled, but this does not prevent the condition for sure or reverse damage that is already present. Not smoking, taking diabetes treatment as prescribed, and supporting overall diabetes health with food choices, physical activity, and sleep may also help, although these steps mainly lower the risk of further damage rather than directly stopping it. Because this stage of diabetic eye disease can change quickly, regular dilated eye exams and early treatment if the eye starts to swell or grow fragile new blood vessels are important, and while these steps can lower the chance of vision loss, they cannot promise a certain outcome.
What genetics can tell you about symptoms
Genetics may play a small role in how likely someone with diabetes is to develop severe nonproliferative diabetic retinopathy and how quickly it worsens, but this is not something genetic testing can usually predict well for an individual. For many people, symptoms such as blurred vision may not appear until the disease is already advanced, and day-to-day factors like blood sugar, blood pressure, kidney health, and how long someone has had diabetes have a much stronger effect on when eye changes begin and how serious they become. In other words, genetics may slightly shape risk, but they do not clearly tell you which symptoms you will have, how severe they will be, or exactly when they will start.
Causes and risk factors
Blurred or patchy vision can build quietly over time, and severe nonproliferative diabetic retinopathy usually develops after years of high blood sugar damaging the small blood vessels in the retina. The main risk factors for severe nonproliferative diabetic retinopathy are having diabetes for a long time and having blood sugar that often stays above your target range. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). High blood pressure, high cholesterol, kidney disease, pregnancy, and smoking can all raise the chance of this stage of diabetic eye disease. Family history may also play a part, and limited access to regular diabetes care and eye exams can make severe retinal damage more likely.
What are the most common causes or risk factors?
Severe nonproliferative diabetic retinopathy is mainly caused by long-term diabetes damaging the tiny blood vessels in the light-sensing tissue at the back of the eye. The biggest risk factors are having diabetes for many years, blood sugar that stays high over time, high blood pressure, high cholesterol, kidney disease, smoking, and sometimes pregnancy in people already living with diabetes. Family history may play a small part in who is more likely to develop serious eye damage, but the strongest risks are still how long someone has had diabetes and how well blood sugar and blood pressure are controlled.
Environmental and biological risk factors
Severe nonproliferative diabetic retinopathy becomes more likely when diabetes has been stressing the tiny blood vessels in the back of the eye for a long time. Understanding the main risk factors for severe nonproliferative diabetic retinopathy can help explain why regular eye exams matter, even before vision changes are obvious. Awareness of both biological and environmental influences helps you feel prepared.
The longer someone has diabetes, the more time high sugar levels have to injure the tiny blood vessels in the retina. This makes severe nonproliferative diabetic retinopathy more likely over the years.
Blood sugar that stays high over months and years can weaken vessel walls and make them leak or close off. Large swings in blood sugar can also add stress to the retina.
High blood pressure puts extra strain on already fragile retinal vessels. When diabetes and high blood pressure occur together, eye damage can worsen faster.
Kidney problems often go along with blood vessel damage in other parts of the body, including the eyes. Protein in the urine or reduced kidney function can signal a higher risk of severe diabetic eye disease.
Genetic risk factors
Changes in vision from severe nonproliferative diabetic retinopathy can make reading, driving, or seeing fine detail much harder. When people ask about genetic risk factors for severe nonproliferative diabetic retinopathy, the main point is that inherited traits can influence who is more likely to develop severe eye damage from diabetes. It’s usually a combination of influences rather than one clear cause. For most people, family history and many small genetic differences matter more than a single disease-causing gene.
Family history: Having a close relative with diabetic retinopathy can raise your chance of developing severe eye disease too. This does not mean it will definitely happen, but it is one of the clearest signs that inherited factors matter.
Many small variants: In most people, risk comes from many small genetic differences rather than one single faulty gene. This is why genetic testing usually cannot give a simple yes-or-no answer about who will develop severe nonproliferative diabetic retinopathy.
Blood vessel genes: Some inherited differences affect how the tiny blood vessels in the retina handle stress from diabetes. Over time, these traits may make leakage, blockage, and reduced oxygen supply more likely.
Inflammation pathways: Genes that influence inflammation and the body’s response to cell damage may also shape risk. This may help explain why two people with diabetes can have very different levels of retinal damage.
Ancestry patterns: Severe diabetic eye disease is seen more often in some ancestry groups than others, which suggests genetics may play a role. Ancestry alone cannot predict what will happen, because it reflects broad inherited patterns rather than a single cause.
Inherited diabetes forms: Rare inherited types of diabetes can increase the lifetime chance of retinal complications, especially when diabetes begins early. In these cases, the underlying genetic condition may contribute to a higher risk of severe retinopathy.
Lifestyle risk factors
Severe nonproliferative diabetic retinopathy can worsen faster when diabetes control is inconsistent over time. The main lifestyle risk factors center on daily habits that affect blood sugar, blood pressure, cholesterol, and follow-through with treatment. When people ask about lifestyle risk factors for severe nonproliferative diabetic retinopathy, the most important ones are the habits that increase stress on the small blood vessels in the retina.
Frequent high blood sugar can damage retinal blood vessels and speed progression of diabetic retinopathy. Skipping glucose monitoring, irregular meals, or inconsistent diabetes self-care can make vision-threatening changes more likely.
A diet high in refined carbohydrates, sugary drinks, and highly processed foods can make glucose control harder and increase vascular stress. Eating patterns that support steadier blood sugar and healthier cholesterol levels may help slow further retinal damage.
Low activity levels can worsen insulin resistance and make blood sugar, blood pressure, and weight harder to manage. Regular movement can support overall diabetes control, which may reduce strain on the retina.
Smoking harms blood vessels and reduces oxygen delivery to tissues, including the retina. It can add to the vascular injury already caused by diabetes and increase the chance of retinopathy getting worse.
Risk prevention
Severe nonproliferative diabetic retinopathy can make everyday tasks like reading labels, driving at night, or recognizing faces feel harder, even before vision loss is obvious. The best way to lower the risk of developing it, or keep it from getting worse, is to keep blood sugar, blood pressure, and cholesterol in a healthy range and to have regular eye exams. Prevention works best when combined with regular check-ups.
Keeping blood sugar as close to your target range as possible lowers stress on the tiny blood vessels in the retina. Over time, steady control can reduce the risk of severe nonproliferative diabetic retinopathy and slow worsening if changes have already started.
High blood pressure can add extra strain to already fragile retinal blood vessels. Treating it with daily habits and medicines when needed can help protect vision.
Unhealthy cholesterol and triglyceride levels can increase leakage from retinal vessels and may worsen diabetic eye disease. Food choices, exercise, and prescribed medicines can all help lower this risk.
Dilated eye exams can find early symptoms of severe nonproliferative diabetic retinopathy before you notice clear changes in sight. Catching problems early gives your eye specialist more chances to monitor and treat them in time.
Can you prevent Severe nonproliferative diabetic retinopathy?
You cannot always fully prevent this advanced stage of diabetes-related eye disease, but you can often lower the risk a lot. The most proven steps are keeping blood sugar, blood pressure, and cholesterol under good control, taking diabetes treatment as advised, not smoking, and having regular diabetic eye exams so problems can be found and treated early. Even with good care, some people living with diabetes still develop it, which is why steady follow-up matters.
Transmission
Severe nonproliferative diabetic retinopathy is not contagious, so it cannot be passed from one person to another through coughing, touching, sex, blood, or sharing food and drinks. This stage of diabetic eye disease develops when diabetes damages the tiny blood vessels in the retina over time, not because of a virus, bacterium, or other infection.
If you are wondering whether severe nonproliferative diabetic retinopathy is contagious, the answer is no. What can run in families is the tendency to develop diabetes, which may indirectly raise the risk of diabetic eye disease, but the retinopathy itself is not transferred between people.
When to test your genes
For severe nonproliferative diabetic retinopathy, genetic testing is not part of routine early detection or treatment planning. What matters most is regular dilated eye exams, especially if you have diabetes, along with tight blood sugar, blood pressure, and cholesterol control. Genetic testing may only be considered in unusual cases if your eye specialist suspects a different inherited retinal condition.
Diagnosis
Blurred vision, trouble reading, or needing more light for routine tasks can be the first signs that something is changing in the back of the eye. For many, the first step comes when everyday activities start feeling harder. The diagnosis of severe nonproliferative diabetic retinopathy is usually made during a dilated eye exam, then confirmed by looking closely at the retina and its blood vessels.
An eye doctor places drops in your eyes to widen the pupils and get a clear view of the retina. This lets them look for bleeding, fatty deposits, swollen areas, and widespread blood vessel damage that fit severe nonproliferative diabetic retinopathy.
Doctors look for patterns such as many retinal hemorrhages, cotton-wool spots, and abnormal veins that suggest reduced blood flow. These imaging findings and exam features help separate severe disease from milder diabetic eye changes.
Special photographs of the inside of the eye can document changes and make it easier to compare visits over time. They are often used as part of how severe nonproliferative diabetic retinopathy is diagnosed and monitored.
Optical coherence tomography, often called OCT, uses light waves to create detailed cross-section images of the retina. It helps show whether fluid has built up in the macula, which can affect central vision and change treatment planning.
How is Severe nonproliferative diabetic retinopathy diagnosed?
Severe nonproliferative diabetic retinopathy is usually diagnosed during a full eye exam after the pupils are widened with drops, so an eye doctor can look closely at the retina, the light-sensitive tissue at the back of the eye. The diagnosis is based on seeing many areas of diabetes-related damage, such as bleeding, blocked tiny blood vessels, and swelling, but without the new abnormal blood vessels that mark a later stage of the disease. Photos or scans of the back of the eye, and sometimes a dye test that shows blood flow, may also be used to confirm how advanced it is and help plan treatment.
Stages of Severe nonproliferative diabetic retinopathy
Severe nonproliferative diabetic retinopathy does not have defined progression stages. This is because it is already a specific point on the diabetic retinopathy spectrum, rather than a condition that is usually divided into smaller step-by-step phases. Doctors usually start with a conversation about vision changes, blood sugar history, and the early symptoms of severe nonproliferative diabetic retinopathy, but the condition is mainly identified through a dilated eye exam and retinal imaging. Ongoing follow-up is used to watch for swelling in the macula or progression to proliferative diabetic retinopathy, which can raise the risk of sudden vision loss.
Outlook and prognosis
The outlook for severe nonproliferative diabetic retinopathy depends largely on how well blood sugar, blood pressure, and cholesterol are controlled and how quickly the condition is treated and monitored. Without timely follow-up, the risk of progression to proliferative diabetic retinopathy or diabetic macular edema is high, which can lead to major and sometimes permanent vision loss. With regular retinal exams, management of systemic risk factors, and treatment when needed, many people can slow progression and preserve useful vision for years. Vision prognosis is worse if there is coexisting macular edema, poor diabetes control, kidney disease, or delayed access to eye care. Severe nonproliferative diabetic retinopathy itself is not usually a direct cause of death, but it is a marker of advanced diabetic blood vessel disease and is associated with a higher risk of cardiovascular events, kidney complications, and overall mortality compared with people who do not have diabetic retinopathy.
Long-term effects
Severe nonproliferative diabetic retinopathy can affect vision over time, even before someone notices obvious changes day to day. At this stage, the retina has widespread damage from diabetes, which raises the risk of moving into a more dangerous phase with fragile new blood vessels. Long-term effects vary widely, but blurred sight, trouble with detailed tasks, and a higher chance of vision loss are common concerns. For many, this can mean reading bills more slowly, struggling with night driving, or needing brighter light for routine tasks.
Severe nonproliferative diabetic retinopathy can lead to lasting damage in the light-sensitive tissue at the back of the eye. Over time, this may cause partial vision loss or, in some people, severe loss of sight if the disease keeps progressing.
Swelling in the center of the retina, called macular edema, can make faces, print, and phone screens look blurry or warped. This may come and go at first, but it can become a long-term problem if the swelling persists.
This stage has a high risk of progressing to proliferative diabetic retinopathy, where abnormal new blood vessels grow in the eye. That later stage can bring bleeding, scar tissue, and a much greater threat to vision.
Damaged retinal vessels can leak blood into the clear gel inside the eye, causing floaters or cloudy vision. If bleeding is heavier, sight may suddenly drop and recovery can take time even with treatment.
How is it to live with Severe nonproliferative diabetic retinopathy?
Living with severe nonproliferative diabetic retinopathy can feel unsettling because vision may still seem fairly usable day to day, yet the retina is showing clear signs of strain and a higher risk of progressing to sight-threatening disease. Many people notice blurred vision, trouble reading, reduced contrast, or difficulty driving at night, and daily life often becomes more structured around blood sugar control, blood pressure care, regular eye visits, and sometimes help with transportation or detailed tasks. This can affect the people around you too, as family members may step in for rides, reminders, or emotional support, but with close follow-up and good diabetes care, many people can stay active and protect their vision as much as possible.
Treatment and drugs
In severe nonproliferative diabetic retinopathy, treatment focuses on lowering the chance of vision loss by controlling diabetes and watching closely for signs that the disease is moving into a more dangerous stage. For many people, this means tighter blood sugar control, along with careful treatment of high blood pressure and cholesterol, because these steps can slow further damage in the retina. Eye doctors often recommend regular follow-up visits with retinal imaging, since early symptoms of severe nonproliferative diabetic retinopathy may be mild or absent even while changes are worsening. If swelling in the center of the retina or new abnormal blood vessels develop, treatment may include eye injections, laser treatment, or sometimes surgery, depending on what is happening inside the eye. Not every treatment works the same way for every person, and your eye specialist can help decide when close monitoring is enough and when active treatment is needed.
Can you cure Severe nonproliferative diabetic retinopathy?
No, there is no cure for severe nonproliferative diabetic retinopathy, an advanced stage of diabetes-related damage in the back of the eye. The damage that has already happened often cannot be fully reversed, but keeping blood sugar, blood pressure, and cholesterol well controlled, along with regular eye care and treatments such as medicine injections into the eye or laser treatment when needed, can slow it down and help protect vision.
Non-drug treatment
Daily care matters a great deal in severe nonproliferative diabetic retinopathy, because vision can still seem mostly normal even while the retina is under strain. Managing this condition often means combining close eye follow-up with steady control of diabetes and heart-health risks. For many, treatment for severe nonproliferative diabetic retinopathy begins with steps that lower the chance of further damage and help catch changes before vision is affected. If swelling, bleeding, or progression develops, office-based procedures may also become part of care.
Keeping blood sugar in a healthy range can slow further injury to the small blood vessels in the retina. This usually involves regular monitoring, meal planning, physical activity, and follow-through with your diabetes care plan.
High blood pressure can add stress to already fragile retinal blood vessels. Checking and improving blood pressure, and also managing cholesterol, can lower the risk of worsening eye disease and other diabetes complications.
Regular exercise, balanced eating, weight management, and not smoking support better blood flow and overall diabetes control. Even small changes can lead to steadier numbers over time, which may help protect vision.
Regular dilated eye exams and retinal scans help your eye specialist track whether severe nonproliferative diabetic retinopathy is staying stable or moving closer to advanced disease. This is especially important because the early symptoms of severe nonproliferative diabetic retinopathy can be mild or absent.
Your genes may have an impact on how drugs work for you
For people living with severe nonproliferative diabetic retinopathy, genes may play a small part in how well some treatments work, including diabetes medicines that help control blood sugar and eye injections used when swelling or worsening eye damage is present. Some may respond better than others, or have a higher chance of side effects, because the body can process medicines at different speeds, but blood sugar levels, blood pressure, kidney health, and how advanced the eye disease is usually matter more in day-to-day care. At this point, gene-based drug matching, sometimes called pharmacogenomics, is not a routine part of treatment for this eye condition.
Pharmacological treatments
In severe nonproliferative diabetic retinopathy, medicines are mainly used to lower the risk of the disease worsening and to treat related swelling in the retina. The most common eye drugs are anti-VEGF injections, while steroid medicines may be used in some people, especially when diabetic macular edema is also present. Not everyone responds to the same medication in the same way.
Aflibercept is an anti-VEGF eye injection that can help slow severe nonproliferative diabetic retinopathy and reduce the chance of progression to sight-threatening disease. It is given by an eye specialist, usually as repeated injections over time.
Ranibizumab is another anti-VEGF injection used to treat diabetic retinopathy and related retinal swelling. For many, this can mean fewer abnormal blood vessel changes and a lower risk of vision loss with ongoing treatment.
Faricimab is a newer injected medicine used for diabetic eye disease, especially when diabetic macular edema is part of the picture. Some medicines work quickly, while others need repeat dosing and follow-up visits before the full benefit is clear.
Steroid medicines such as triamcinolone, dexamethasone implant, and fluocinolone implant may be used when retinal swelling is not controlled well enough with other treatment or when anti-VEGF drugs are not suitable. These drugs can help reduce inflammation and fluid, but they can also raise eye pressure or speed up cataract formation.
Genetic influences
Severe nonproliferative diabetic retinopathy does not come from one single “retinopathy gene,” but inherited differences in how the body handles blood sugar, inflammation, and blood vessel repair can make some people more likely to develop it or to have it progress faster. This may help explain why two people with diabetes for a similar number of years can have very different eye changes. Family history is one of the strongest clues to a genetic influence. Even so, genes are only part of the picture, and having a genetic risk is not the same as having the disease itself. For many living with severe nonproliferative diabetic retinopathy, day-to-day factors such as blood sugar levels, blood pressure, cholesterol, kidney health, and smoking still play a major role in whether damage builds up in the retina. At this point, doctors do not use a routine genetic test to predict severe nonproliferative diabetic retinopathy, so the most useful step is usually to share family history and keep up with regular diabetic eye exams.
Is Severe nonproliferative diabetic retinopathy genetic?
Genes can influence who is more likely to develop Severe nonproliferative diabetic retinopathy and how fast it worsens, but they are only part of the picture. Blood sugar, blood pressure, and diabetes duration usually matter more than inherited genetic variations.
Having a genetic risk is not necessarily a diagnosis
Most genetic variants do not directly affect health and are simply part of natural human diversity. They are common in the general population and are a normal part of human biology. For many genes, carrying a variant linked to a condition indicates a possible association rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some cases, though, one well-understood variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with severe nonproliferative diabetic retinopathy, treatment decisions are guided mostly by what the eye doctor sees on exam, how well diabetes is controlled, and whether there is vision-threatening swelling, not by a genetic test. Genes do seem to play some part in how strongly diabetes affects the retina and how some people respond to medicines, but this area is still being studied. Not every difference in response is genetic, but inherited differences can sometimes affect how your body handles diabetes medicines, including the chance of side effects or how much benefit you get. Researchers are also looking at whether certain gene patterns help explain why anti-VEGF eye injections work very well for some people and less well for others, although doctors do not routinely use this information yet. Right now, genetic testing for severe nonproliferative diabetic retinopathy is not part of standard care, and most treatment plans focus on blood sugar, blood pressure, cholesterol, and close eye follow-up, with injections or laser treatment when needed. If treatment is not helping as expected, your eye doctor and diabetes clinician usually look at the full picture rather than genetics alone.
Interactions with other conditions
Severe nonproliferative diabetic retinopathy often does not happen in isolation, and many living with it also have other diabetes-related health problems that can affect the eyes and overall health. It can be more difficult to manage when blood sugar stays high over time or when high blood pressure, kidney disease, or high cholesterol are also present, because these problems can further strain the tiny blood vessels in the retina. Someone might notice their vision becomes blurrier during periods when diabetes or blood pressure is less controlled, even before a routine eye exam shows clear changes. Severe nonproliferative diabetic retinopathy is also closely linked with cardiovascular disease, so its presence can be a sign that blood vessels elsewhere in the body may be under stress too. Cataracts and glaucoma may occur alongside diabetic eye disease and can add to sight problems, making it harder to tell which condition is causing a change in vision without a full eye exam. Because the early symptoms of severe nonproliferative diabetic retinopathy can be mild or absent, regular follow-up is especially important if you are also living with kidney disease, heart disease, or other complications of diabetes.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Severe nonproliferative diabetic retinopathy?
Other eye problems can cause similar changes, especially blurred vision, floaters, or patchy sight. Common examples include age-related macular degeneration, cataracts, glaucoma, a blocked blood vessel in the back of the eye, and eye damage from high blood pressure. Because these can overlap, and severe nonproliferative diabetic retinopathy may cause few symptoms at first, a full eye exam is usually needed to tell them apart.
History
Long before eye cameras and laser treatment existed, doctors noticed that some people with diabetes gradually developed blurred vision, dark spots, or trouble seeing fine detail even when their blood sugar problems seemed to be the main issue. What we now call severe nonproliferative diabetic retinopathy was recognized as part of a broader pattern of diabetes-related eye damage, often discovered only after vision had already started to change in daily life, such as struggling to read labels, recognize faces across a room, or drive at night.
In recent decades, awareness has grown as better eye exams made it easier to see the small blood vessel changes happening in the retina, the light-sensitive layer at the back of the eye. Early descriptions of diabetic eye disease were fairly broad, but over time specialists learned to separate mild, moderate, and severe stages based on how much damage could be seen. Severe nonproliferative diabetic retinopathy came to mean an advanced stage in which many retinal blood vessels are injured or blocked, but new abnormal vessels have not yet started to grow. That distinction mattered because it helped doctors identify who was at high risk for further vision-threatening disease.
As medical science evolved, photographs of the retina, fluorescein angiography, and later optical coherence tomography gave a much clearer picture of what was happening inside the eye. This changed care in a practical way: instead of waiting for major vision loss, doctors could monitor people with diabetes more closely and treat complications earlier. Research also showed that careful blood sugar control, along with managing blood pressure and cholesterol, could lower the chance of diabetic retinopathy getting worse.
Today, the history of severe nonproliferative diabetic retinopathy is closely tied to screening and prevention. Many living with diabetes have no obvious early symptoms of severe nonproliferative diabetic retinopathy, which is why regular dilated eye exams became such an important part of routine care in both the US and Europe. Looking back at how this condition was recognized helps explain a key message that still matters now: vision can often be protected when retinal changes are found before they begin to interfere too much with everyday life.